Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RBI-257: a highly potent dopamine D4 receptor-selective ligand

N S Kula1, R J Baldessarini, J W Kebabian

  • 1Consolidated Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA.

European Journal of Pharmacology
|July 23, 1997
PubMed
Summary

RBI-257, a novel dopamine D4 receptor ligand, demonstrates higher selectivity and affinity compared to U-101,958. This compound shows promise as a research tool for studying dopamine D4 receptors in the brain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

6,7-Dihydroxy-2-dimethylaminotetralin (TL-99) stimulates postjunctional D-1 and D-2 dopamine receptors.

Neurochemistry international·2010
Same author

Desensitization of the D-2 dopamine receptor and the ?(2)-adrenoceptor in the intermediate lobe of the rat pituitary gland.

Neurochemistry international·2010
Same author

Preliminary study on the expression of HLA-G mRNA in normal placenta and placenta with RSA after immunotherapy.

Transplantation proceedings·1999
Same author

Normal changes in spinal bone mineral density in a Chinese population: assessment by quantitative computed tomography and dual-energy X-ray absorptiometry.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·1999
Same author

Oligomerization state influences the degradation rate of 3-hydroxy-3-methylglutaryl-CoA reductase.

The Journal of biological chemistry·1999
Same author

CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes.

European journal of immunology·1999

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Dopamine receptors, particularly the D4 subtype, are implicated in various neurological functions and disorders.
  • Selective ligands for dopamine D4 receptors are valuable tools for research and potential therapeutic development.

Purpose of the Study:

  • To characterize the binding affinity and selectivity of RBI-257, a novel analog of U-101,958, at dopamine D4 receptors.
  • To compare the pharmacological profile of RBI-257 with its parent compound, U-101,958.

Main Methods:

  • Radioligand binding assays were performed using transfected cell membranes expressing specific dopamine receptor subtypes.
  • Binding affinities and selectivities were assessed against dopamine D2, D3, D1, and D5 receptors.
  • Inhibition constants (Ki) were determined to quantify receptor binding.

Related Experiment Videos

Main Results:

  • RBI-257 exhibited a significantly lower dissociation constant (Ki = 0.3 nM) compared to U-101,958 (Ki = 2.7 nM) at dopamine D4 receptors.
  • RBI-257 demonstrated higher selectivity for dopamine D4 receptors over D2 and D3 receptors.
  • The para-iodo isomer of RBI-257 showed the highest affinity for dopamine D4 receptors.
  • RBI-257 displayed minimal affinity for other dopamine receptor subtypes (D1, D5), adrenergic, sigma, and serotonin receptors.

Conclusions:

  • RBI-257 possesses superior affinity and selectivity for dopamine D4 receptors compared to U-101,958.
  • RBI-257 represents a promising chemical probe or radioligand for investigating dopamine D4 receptors in the brain.